|Published||Report Code||Available Format||Pages|
The global scar treatment market size stood at $19.6 billion in 2019, and it is expected to reach $63.4 billion by 2030, exhibiting a CAGR of 11.5% during the forecast period (2020–2030). The major factors supporting the growth of the industry include the high prevalence of skin diseases, surging disposable income, rising awareness among individuals about scar treatment, rising appearance consciousness, and focus on the introduction of technologically advanced scar treatments.
The COVID-19 pandemic has impacted almost all industries across the world, including the scar treatment market. The demand for scar treatment products would witness a negative impact in the short run (till the third quarter of 2020), thus leading to a reduction in the market growth rate. However, these products are expected to witness a notable increase in demand from the last quarter of 2020, after the restarting operations in manufacturing plants, lifting of lockdowns, reopening of skin clinics, and resumption in the import and export of these products.
The laser category is expected to witness the fastest growth in the scar treatment market during the forecast period. Laser treatments are more advanced treatments for scars compared to the various topical ointments available, as the former help in reducing scars within a few hours to a few days. These treatments allow for the re-organization of the cells within the scarred tissues and help in building collagen, thus healing the scars in a shorter span of time. Thus, the high demand for laser treatments for scars is expected to contribute significantly toward the market growth.
On the basis of scar type, the keloid and hypertonic category is expected to witness the fastest growth during the forecast period. This would mainly be due to the increasing number of surgical procedures, burn injuries, and traumatic wound cases. As a result, treatments including laser therapy and those utilizing silicone sheets are increasing in volume, which is further resulting in the rapid growth of the scar treatment market.
The home-use category held the largest share in the scar treatment market in 2019, under the end user segment. This was mainly due to the heavy usage of topical scar treatment products at homes. Some of the benefits offered by these home-use products include easy application, affordability, fewer side-effects, and reduction in the overall appearance of the scars, which encourage individuals to use them at home.
North America dominated the scar treatment market during the historical period (2014–2019). The major factors supporting its dominance include the high disposable income here, which is further resulting in the increasing spending on personal care products. Moreover, the surging appearance consciousness among the population in the region has led to a rising adoption of advanced scar treatment products. Additionally, the growing prevalence of skin diseases and burns incidences is fueling the demand for scar treatment products in the region.
Geographically, the fastest growth in the scar treatment market is expected in the APAC region in the coming years. The growing awareness about scar treatments is driving the demand for associated products and services in the region. The inclination toward over-the-counter (OTC) scar treatment products is increasing, as they have a lower price as compared to prescription drugs. Additionally, the availability of advanced laser treatments and surgeries for all types of scars, which offer results in a comparatively lesser time, also drives the regional market. The increasing research activities in the region have resulted in the development of advanced products.
The preference for silicone-based scar treatment products is a key trend being observed in the scar treatment market. Silicone-based products, such as gels and gel sheets, are effective for reducing scars, which is why they are recommended by cosmetic surgeons and doctors worldwide. Silicone gels, which are used as ultra-thin sheets, work for 24 hours on the skin after their application.
Some of the silicone-based scar removal products available in the scar treatment market include Avosil scar care ointment by Avocet Polymer Technologies Inc., Kelo-cote scar gel and ScarAway by Perrigo Company plc, and Xeragel by Biodermis Corporation. Silicone-based products are more efficient in treating scars and offer advantages such as easy application, protection from harmful sunrays, and prevention of bacterial invasion, which will further result in a significant growth in the demand for such products.
The prevalence of skin diseases is a major factor driving the growth of the scar treatment market globally. Skin diseases, such as psoriasis, eczema, vitiligo, and photoaging, are increasing in prevalence due to the excessive exposure to pollution and ultraviolet (UV) radiation, which results in sunburns, reduced skin elasticity, and hair loss. These conditions, without proper treatment and management on time, can lead to the formation of scars. Various other skin problems, such as acne, burns, post-surgical marks, and stretch marks due to pregnancy or changes in body weight, can also lead to scar formation. Acne is the most common dermatological condition that has affected the majority of the world population; it can eventually lead to scarring. In order to treat this skin disease and overcome the harmful effects of UV radiation, scar treatment products are used.
Various activities, such as dermatology conference and workshops, are being conducted by different associations to create awareness among people regarding the new skin treatments available, including for scar treatment, and the improvements being made in the existing methods. The American Society for Laser Medicine & Surgery Inc. (ASLMS), European Dermatology Congress, Organization for Burns, Scar After-Care and Research (OSCARE), and other such organizations are engaged in creating awareness.
Some of the conferences by these associations include the ASLMS Conference 2019 on Energy-Based Medicine and Science, 20th European Dermatology Congress (held in April 2020), and Global Meet on Skin Care and Plastic Aesthetics, which is scheduled for November 2020. As a result, the overall awareness among people with respect to the various options available for scar treatment is increasing, which is further propelling the growth of the scar treatment market.
|Base Year (2019) Market Size||$19.6 Billion|
|Forecast Period (2020-2030) CAGR||11.5%|
|Report Coverage||Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies’ Strategic Developments, Product Benchmarking, Company Profiling|
|Market Size by Segments||Treatment Type, Scar Type, End User, Region|
|Market Size of Geographies||U.S., Canada, U.K., Germany, France, Italy, Spain, China, Japan, India, U.A.E., Saudi Arabia, South Africa, Brazil, Mexico|
|Secondary Sources and References (Partial List)||American Academy of Dermatology, American Burn Association, European Wound Management Association, International Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, American Society for Laser Medicine & Surgery, International Society of Dermatology, World Health Organization, United Nations Department of Economic and Social Affairs|
The global scar treatment market is fragmented in nature, and the majority of the players are focusing on the launch of new products for increased trust with customers and expanding in the industry.
The scar treatment market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.
Based on Treatment Type
Based on Scar Type
Based on End User
The scar treatment market will advance at a CAGR of 11.5% during 2020–2030.
COVID-19 has had a negative impact on the scar treatment industry.
The scar treatment market is fragmented in nature.
Gels and gel sheets are the most-widely recommended silicone-based products for cosmetic surgery in the scar treatment industry.
Scar treatment market end users are adopting TOC products because these are cheaper than prescription drugs.